Advertisement

Topics

Latest "Delaware's Partnership to Fight Chronic Disease" News Stories

11:14 EST 12th December 2017 | BioPortfolio

Here are the most relevant search results for "Delaware's Partnership to Fight Chronic Disease" found in our extensive news archives from over 250 global news sources.

More Information about Delaware's Partnership to Fight Chronic Disease on BioPortfolio

In addition to our news stories we have dozens of PubMed Articles about Delaware's Partnership to Fight Chronic Disease for you to read. Along with our medical data and news we also list Delaware's Partnership to Fight Chronic Disease Clinical Trials, which are updated daily. BioPortfolio also has a large database of Delaware's Partnership to Fight Chronic Disease Companies for you to search.

Showing "Delaware Partnership Fight Chronic Disease" News Articles 1–25 of 20,000+

Tuesday 12th December 2017

CareMore Health Expands its Provider Collaboration Network through MemorialCare Agreement

Expanded Agreement will Give CareMore Health Patients Access to MemorialCare Providers and Medical Centers CareMore Health will increase its provider collaboration network under an expanded agreement with MemorialCare effective January 1, 2018. Individuals enrolled in specific Anthem Blue Cross Medicare Advantage plans that receive their health care th...


Ceres Nanosciences Announces Plans for Significant Growth in Prince William County, Virginia

Ceres Nanosciences (Ceres) is pleased to announce its recent expansion in Prince William County, Virginia. Following a successful fundraising round in 2017, Ceres has rapidly expanded both its staff and its facilities to accommodate the growing demand for the novel Nanotrap® particle platform across the life sciences industry. The Nanotrap® particle prov...

IHI Kicks Off 2017 National Forum on Quality Improvement in Health Care

When patients and their clinical teams work as partners, it’s more than a nice idea. There’s a greater likelihood of better outcomes for patients and greater satisfaction for health care providers, many of whom have been suffering high rates of burnout in recent years. Institute for Healthcare Improvement (IHI) President and CEO, Derek Feeley, chose th...


One Call and SEPTA Experts Outline Strategies to Manage Claims with Comorbidities at the National Workers’ Compensation & Disability Conference

Early intervention, holistic care and wellness programs help identify and address today’s most common and costly comorbid conditions It’s now become a common occurrence to have injured workers suffer from another condition or disease – such as obesity, diabetes or depression – while recovering from a workplace injury. If a comorbidity exists, the ...

Digital Health Innovators Stephanie Peng and Raymond Lee Join Vida Health To Scale Digital Therapeutics For Large Employers

New hires to play key role in Vida’s enterprise expansion. SAN FRANCISCO (PRWEB) December 12, 2017 Vida Health, a digital therapeutic platform that helps employees overcome chronic physical and behavioral health problems, today announced the hires of Stephanie Peng, formerly of Livongo, and Raymond Lee, formerly of Proteus Health, as Chief Financial Officer and Vice President of Product, respec...

TetraGenetics Partners with LifeArc to Humanize New Drugs and Perform IND-Enabling Studies

TetraGenetics, a biopharmaceutical company developing novel therapeutics for autoimmune diseases and pain, today announced a partnership with LifeArc®, the UK-based medical research charity. The collaboration brings together the drug discovery skills of TetraGenetics with the antibody humanization and development capabilities of LifeArc. Under the agreeme...

Health Dialog Achieves 15 Consecutive Years of NCQA Accreditation for Disease Management Programs

Disease management programs meet rigorous standards for patient care and continuous quality improvement Health Dialog, a leading provider of integrated population health management solutions for health plans, risk-bearing providers and self-insured employers, announced today that it has received Patient Oriented Accreditation from the National Committe...

Multiple Sclerosis Disease Modifying Therapies Market to Reach $25B by 2026

ArticleThe current MS market is becoming increasingly competitive, with a large number of drugs that offer relatively good safety but only moderate efficacy.

Cone Health and Babyscripts Partner to Provide Pregnancy Care for Higher Risk Patients

Pilot Program to Focus on Gestational Diabetes Care GREENSBORO, N.C. (PRWEB) December 12, 2017 Cone Health, a private, not-for-profit, health care network based in Greensboro, North Carolina has partnered with Babyscripts, the first mobile clinical tool to allow OB/GYNs to remotely monitor their pregnant patients’ progress and health, to develop a way to monitor gestational diabetes remotely. W...

Optimum Healthcare IT Completes Ground-Breaking Connect Project

First Academic Medical Center Epic Connect Project in the US Optimum Healthcare IT, a Best in KLAS healthcare IT consulting services company, announced today the successful completion of the first academic medical center Connect project in the country between UCI Health (UCI) and UC San Diego Health (UCSD). The new strategic partnership between ...

Distributed Bio, Inc. and Pandion Therapeutics, Inc. Announce Multi-Target Collaboration

Distributed Bio, the global leader in computational optimization of fully human monoclonal antibody libraries, today announced a multi-target partnership with Pandion Therapeutics Inc. Distributed Bio will use its proprietary SuperHuman antibody library platform to discover therapeutic ready pre-optimized antibodies against multiple Pandion targets. Pandio...

Agendia: Key Studies Presented at the San Antonio Breast Cancer Symposium Demonstrate the Important Role of MammaPrint® for Patient Pre-Selection, Cost-Effectiveness and For Younger Patients

Data from the I-SPY 2 trial showed the first long-term survival results for patients pre-selected as MammaPrint high-risk, with 94% of the patients who achieved pathological complete response event-free at three years MammaPrint assessment is cost effective in clinical high risk patients compared to clinical risk assessment ...

New Survey Finds People Living With HIV With Diarrhea Often Suffer in Silence

A change in the way doctors and patients talk about symptoms could better address this neglected comorbidity in HIV Napo Pharmaceuticals, Inc. (Napo), a human health company developing and commercializing novel gastrointestinal prescription products from plants used traditionally in rainforest areas, and a wholly-owned subsidiary of Jaguar Health, Inc....

Addiction Policy Forum Announces New Initiatives and Partnerships to Address the Opioid Crisis

Programs Provide Tangible Resources for Individuals, Families and Communities Struggling with Addiction Today, the Addiction Policy Forum announced several new initiatives to help millions of families in the United States struggling with opioid addiction and other substance use disorders. The programs put in motion key elements of the organization’s ...

Nature's Recent Scientific Reports Publication Describes How Apabetalone May Be a Powerful Agent Against HIV-1

CALGARY, Alberta, Dec. 12, 2017 (GLOBE NEWSWIRE) -- Resverlogix Corp. ("Resverlogix" or the "Company") (TSX:RVX) announced today that a recent Nature Scientific Reports has published a 12 page publication on BET (bromodomain and extra-terminal) inhibitors; RVX-208 (apabetalone) and PFI-1 owned by Resverlogix and Pfizer, respectively.  The publication by Lu et al, "B...

Vertex and CRISPR Therapeutics to Co-Develop and Co-Commercialize CTX001 as CRISPR/Cas9 Gene Edited Treatment for Sickle Cell Disease and β-Thalassemia

-Vertex selects CTX001 as first gene edited treatment to be developed as part of collaboration with CRISPR Therapeutics- -Clinical Trial Application for CTX001 submitted in Europe to support initiation of Phase 1/2 clinical study in β-thalassemia in 2018- -Preclinical data for CTX001 presented this week at the American Society for Hemato...

Kaleido Biosciences Expands Leadership Team with Appointment of Alison Lawton as President and Chief Operating Officer

Kaleido Biosciences, a clinical-stage biotechnology company developing novel chemistries to unlock the power of the human microbiome, today announced the appointment of Alison Lawton as president and chief operating officer. Ms. Lawton has more than 30 years of experience in a range of executive and operating roles in the biopharmaceutical industry. ...

Dextera Surgical Files for Chapter 11 Bankruptcy and Signs Asset Purchase Agreement With Aesculap, Inc.

Dextera Surgical Inc. (Nasdaq: DXTR), a company developing and commercializing the MicroCutter 5/80™ Stapler, today announced that it has filed for voluntary Chapter 11 bankruptcy protection. Concurrently, Dextera Surgical entered into an asset purchase agreement with Aesculap, Inc, an affiliate of B. Braun Group, for approximately $17.3 million. ...

2017 Annual Report: Nation’s Health Faces Rising Rates of Premature Death and Continued Unevenness in Concentration of Health Care Providers

Drug death rate is at its highest level in history of America’s Health Rankings Massachusetts ranks as nation’s healthiest state for the first time ever First ever examination of concentration of mental health providers reveals wide variation America’s health is challenged by an increase ...

Dignity Health Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryDignity Health is a healthcare service provider that offers patient care services. The center provides health care services that include allergy, behavioral health, anesthesiology, cardiology, chronic care, geriatrics, dermatology, emergency medicine, endocrinology, gastroenterology, immunology, internal medicine, occupational health, infectious disease, nephrology, neurology, obstetrics, o...

Blueprint Medicines Corp BPMC Medical Equipment Deals and Alliances Profile [Report Updated: 27112017] Prices from USD $250

SummaryBlueprint Medicines Corp Blueprint is a biotechnology company that develops drugs for the treatment of cancers. The company discovers selective kinase inhibitors for genomically defined cancer subsets. Its pipeline products include BLU285, for treatment resistant gastrointestinal stromal tumors; BLU554, used in hepatocellular carcinoma; BLU667, for retmutations, fusions, and predicted resis...

project44 Launches State-of-the-Art Rail Visibility Solution

The technology provider continues to lead the industry with the most comprehensive single-source of real-time multimodal visibility data. CHICAGO (PRWEB) December 12, 2017 Supply chain visibility has become the top priority as manufacturers and retailers fight to keep up with rising consumer demands. Given that rail freight is an important link in many end-to-end supply chains, top shippers have ...

Nektar Therapeutics NKTR Pharmaceuticals Healthcare Deals and Alliances Profile [Report Updated: 14112017] Prices from USD $250

SummaryNektar Therapeutics Nektar is a biopharmaceutical company. It carries out discovery and development of a pipeline of novel therapeutic drug candidates based on its PEGylation and advanced polymer conjugate technology platforms to address unmet medical needs. Nektar's technology platformns offers a wide array of functional attributes, which optimizes and enhances the profile of wide range of...

NIH to provide funding for Alzheimer's advance clinical trials

US-based National Institutes of Health (NIH) is set to provide financial assistance to a new clinical trials consortium to enhance studies for therapies in Alzheimer’s disease and related dementias.

Alternative Viewpoints and Fallacies of Modern Medicine

Robert S. Farmer M.D. authors new book on how to cure many chronic illnesses on your own BALTIMORE (PRWEB) December 12, 2017 Dr. Robert S. Farmer demonstrates that many common, chronic diseases such as obesity and diabetes are usually not genetic and are only rarely viral. Most commonly, they are the result of parasitic infections that virtually all first-world doctors refuse to acknowledge prope...


Quick Search
Advertisement
 

News Quicklinks